![](/img/cover-not-exists.png)
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
Nahi, Hareth, Våtsveen, Thea Kristin, Lund, Johan, Heeg, Bart M.S., Preiss, Birgitte, Alici, Evren, Møller, Michael Boe, Wader, Karin Fahl, Møller, Hanne E.H., Grøseth, Lill Anny, Østergaard, Brian, DLanguage:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.12546
Date:
June, 2015
File:
PDF, 220 KB
english, 2015